Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Brechbiel

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Cancer Biotherapy & Radiopharmaceuticals|June 10, 2004
Radioimmunotherapy of human colon carcinoma xenografts using a 213Bi-labeled domain-deleted humanized monoclonal antibodyDiane Milenic, Kayhan Garmestani, Ekaterina Dadachova, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 18, 2022
Cure of Micrometastatic B-Cell Lymphoma in a SCID Mouse Model Using <sup>213</sup>Bi-Anti-CD20 Monoclonal AntibodyGregory T Havlena, Nirav S Kapadia, Peng Huang, et al.
Bioconjugate Chemistry|September 19, 2002
Trifunctional conjugation reagents. Reagents that contain a biotin and a radiometal chelation moiety for application to extracorporeal affinity adsorption of radiolabeled antibodiesD Scott Wilbur, Ming-Kuan Chyan, Donald K Hamlin, et al.
Cancer Biology & Therapy|August 6, 2005
In vivo and in vitro inhibition of pancreatic cancer growth by targeted alpha therapy using 213Bi-CHX.A"-C595Chang F Qu, Yan J Songl, Syed M A Rizvi, et al.
Cancer Research|August 3, 2005
Concurrent binding of anti-EphA3 antibody and ephrin-A5 amplifies EphA3 signaling and downstream responses: potential as EphA3-specific tumor-targeting reagentsChristopher Vearing, Fook-Thean Lee, Sabine Wimmer-Kleikamp, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 11, 2021
National Cancer Institute support for targeted alpha-emitter therapyJulie A Hong, Martin Brechbiel, Jeff Buchsbaum, et al.
Molecules (Basel, Switzerland)|February 15, 2022
General Method to Increase Carboxylic Acid Content on NanodiamondsGanesh Shenoy, Jessica Ettedgui, Chandrasekhar Mushti, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 30, 2019
Preclinical Evaluation of <sup>203/212</sup>Pb-Labeled Low-Molecular-Weight Compounds for Targeted Radiopharmaceutical Therapy of Prostate CancerSangeeta Ray Banerjee, Il Minn, Vivek Kumar, et al.
Medical Physics|January 27, 2023
The United States Department of Energy and National Institutes of Health Collaboration: Medical Care Advances via Discovery in Physical SciencesCynthia Keppel, Andrew Weisenberger, Tatjana Atanasijevic, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cancer Biotherapy & Radiopharmaceuticals|June 10, 2004
Radioimmunotherapy of human colon carcinoma xenografts using a 213Bi-labeled domain-deleted humanized monoclonal antibodyDiane Milenic, Kayhan Garmestani, Ekaterina Dadachova, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 18, 2022
Cure of Micrometastatic B-Cell Lymphoma in a SCID Mouse Model Using <sup>213</sup>Bi-Anti-CD20 Monoclonal AntibodyGregory T Havlena, Nirav S Kapadia, Peng Huang, et al.
Bioconjugate Chemistry|September 19, 2002
Trifunctional conjugation reagents. Reagents that contain a biotin and a radiometal chelation moiety for application to extracorporeal affinity adsorption of radiolabeled antibodiesD Scott Wilbur, Ming-Kuan Chyan, Donald K Hamlin, et al.
Cancer Biology & Therapy|August 6, 2005
In vivo and in vitro inhibition of pancreatic cancer growth by targeted alpha therapy using 213Bi-CHX.A"-C595Chang F Qu, Yan J Songl, Syed M A Rizvi, et al.
Cancer Research|August 3, 2005
Concurrent binding of anti-EphA3 antibody and ephrin-A5 amplifies EphA3 signaling and downstream responses: potential as EphA3-specific tumor-targeting reagentsChristopher Vearing, Fook-Thean Lee, Sabine Wimmer-Kleikamp, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 11, 2021
National Cancer Institute support for targeted alpha-emitter therapyJulie A Hong, Martin Brechbiel, Jeff Buchsbaum, et al.
Molecules (Basel, Switzerland)|February 15, 2022
General Method to Increase Carboxylic Acid Content on NanodiamondsGanesh Shenoy, Jessica Ettedgui, Chandrasekhar Mushti, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 30, 2019
Preclinical Evaluation of <sup>203/212</sup>Pb-Labeled Low-Molecular-Weight Compounds for Targeted Radiopharmaceutical Therapy of Prostate CancerSangeeta Ray Banerjee, Il Minn, Vivek Kumar, et al.
Medical Physics|January 27, 2023
The United States Department of Energy and National Institutes of Health Collaboration: Medical Care Advances via Discovery in Physical SciencesCynthia Keppel, Andrew Weisenberger, Tatjana Atanasijevic, et al.
Pageof 2